Back
Sarepta Therapeutics Vs. Vertex Pharmaceuticals Industry Stock Comparison
Sell
38
SRPT
Sarepta Therapeutics
Last Price:
128.96
Seasonality Move:
11.13%
Sell
41
VRTX
Vertex Pharmaceuticals
Last Price:
473.24
Seasonality Move:
9.38%
Sell
38
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $130.19. The Score for SRPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $470.36. The Score for VRTX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $130.19
The current trend is moderately bullish and SRPT is experiencing slight selling pressure.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $470.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.05 | Buy |
| Relative Strength Index (14 RSI): | 58.34 | Buy |
| Chaikin Money Flow: | -9031 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.84 - 128.84) | Buy |
| Bollinger Bands (100): | (123 - 147.2) | Sell |
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.97 | Buy |
| Relative Strength Index (14 RSI): | 46.98 | Sell |
| Chaikin Money Flow: | -694359 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (459.72 - 480.22) | Buy |
| Bollinger Bands (100): | (466.75 - 489.05) | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 129.53 | Buy |
| 20-day SMA: | 124.83 | Buy |
| 50-day SMA: | 128.74 | Buy |
| 200-day SMA: | 130.35 | Sell |
| 8-day EMA: | 129.2 | Buy |
| 20-day EMA: | 127.16 | Buy |
| 50-day EMA: | 128.69 | Buy |
| 200-day EMA: | 127.96 | Buy |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 475.3 | Sell |
| 20-day SMA: | 471.67 | Sell |
| 50-day SMA: | 474.66 | Sell |
| 200-day SMA: | 449.8 | Buy |
| 8-day EMA: | 474.62 | Sell |
| 20-day EMA: | 473.7 | Sell |
| 50-day EMA: | 473.42 | Sell |
| 200-day EMA: | 447.68 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.72 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.19 per share, and an increase next year of $8.77 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.89 per share, and an increase next year of $18.49 per share.
Sarepta Therapeutics Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vertex Pharmaceuticals Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||